Gritstone bio, Inc. 10-K, filed Mar 10, 2022: IDEA: XBRL DOCUMENT
Cash Equivalents and Marketable Securities - Additional Information (Detail) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2021
USD ($)
Security
|
Dec. 31, 2020
USD ($)
|
Dec. 31, 2019
USD ($)
|
|
| Cash equivalents and marketable securities [Line Items] | |||
| Cash and cash equivalents and marketable securities | $ 206,300 | $ 171,100 | |
| Cash and cash equivalents | 93,287 | 170,056 | |
| Marketable securities | $ 113,000 | 1,000 | |
| Number of individual securities in an unrealized loss position for 12 months or greater | Security | 0 | ||
| Marketable securities recognition of other-than-temporary impairment | $ 0 | $ 0 | $ 0 |
| Realized gains or losses on marketable securities, description | no material realized gains or losses | ||
| Maximum [Member] | |||
| Cash equivalents and marketable securities [Line Items] | |||
| Marketable securities contractual maturities period | 2 years | ||